Cargando…

suPARnostic(® )as a treatment efficacy monitoring tool in systemic inflammatory response syndrome/sepsis patients

Detalles Bibliográficos
Autores principales:	Eugen-Olsen, Jesper, Kofoed, Kristian, Petersen, Janne, Larsen, Klaus, Andersen, Ove
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300629/ http://dx.doi.org/10.1186/cc7070

Ejemplares similares

suPARnostic: an advanced predictive tool for detecting recurrence in renal cell carcinoma
por: Azawi, Nessn, et al.
Publicado: (2023)

The prognostic value of the suPARnostic(® )ELISA in HIV-1 infected individuals is not affected by uPAR promoter polymorphisms
por: Schneider, Uffe V, et al.
Publicado: (2007)

Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study
por: Kofoed, Kristian, et al.
Publicado: (2007)

Leptin, IL-6, and suPAR reflect distinct inflammatory changes associated with adiposity, lipodystrophy and low muscle mass in HIV-infected patients and controls
por: Langkilde, Anne, et al.
Publicado: (2015)

Plasma suPAR levels are associated with mortality, admission time, and Charlson Comorbidity Index in the acutely admitted medical patient: a prospective observational study
por: Haupt, Thomas Huneck, et al.
Publicado: (2012)

Association between routine laboratory tests and long-term mortality among acutely admitted older medical patients: a cohort study
por: Klausen, Henrik Hedegaard, et al.
Publicado: (2017)

Erratum to: Association between routine laboratory tests and long-term mortality among acutely admitted older medical patients: a cohort study
por: Klausen, Henrik Hedegaard, et al.
Publicado: (2017)

Usefulness of sepsis screening tools and education in recognising the burden of sepsis on hospital wards
por: Galtrey, EJ, et al.
Publicado: (2015)

Inflammation in HIV-Infected Patients: Impact of HIV, Lifestyle, Body Composition, and Demography – A Cross Sectional Cohort Study
por: Langkilde, Anne, et al.
Publicado: (2012)

Automated, electronic monitoring for early detection of sepsis
por: Rauch, S, et al.
Publicado: (2013)

Subcutaneous glucose monitoring in patients with severe sepsis
por: Mader, JK, et al.
Publicado: (2007)

VISZAPP - a tool for rapid patient urgency assessment, admission, and care monitoring and evaluation in emergency departments
por: Andersen, Lykke Burmølle
Publicado: (2010)

Hemodynamic monitoring in severe sepsis and septic shock in German ICUs
por: Jaschinski, U, et al.
Publicado: (2006)

Healthy lifestyles reduce suPAR and mortality in a Danish general population study
por: Haupt, Thomas Huneck, et al.
Publicado: (2019)

Challenges facing the clinical adoption of a new prognostic biomarker: a case study
por: Larsen, Trine Schifter, et al.
Publicado: (2023)

Pyruvate dehydrogenase levels are low in sepsis
por: Nuzzo, E, et al.
Publicado: (2015)

Impact of obesity on outcomes in patients with sepsis
por: Dobesh, PP, et al.
Publicado: (2014)

Improving T-Cell Assays for the Diagnosis of Latent TB Infection: Potential of a Diagnostic Test Based on IP-10
por: Ruhwald, Morten, et al.
Publicado: (2008)

Utility of the Plasma Level of suPAR in Monitoring Risk of Mortality during TB Treatment
por: Rabna, Paulo, et al.
Publicado: (2012)

Monitoring of procalcitonin, IL-6 and brain natriuretic peptide for sepsis diagnosis in cardiac surgery
por: Barchetta, R, et al.
Publicado: (2009)

Does clopidogrel change morbidity and mortality in ICU sepsis patients?
por: Klepser, DG, et al.
Publicado: (2014)

Ultrasonography is a valuable non-invasive tool for determining extravascular lung water in severe sepsis
por: Kok, M, et al.
Publicado: (2011)

The identification and use of common physiologic monitoring parameters in the care of critically ill patients at risk for sepsis
por: Giuliano, Karen, et al.
Publicado: (2007)

Cytokine-mediated regulation of renal urea transporters during sepsis
por: Schmidt, Christoph, et al.
Publicado: (2007)

Long-term mortality among patients with community acquired severe sepsis and septic shock
por: Storgaard, Merete, et al.
Publicado: (2012)

Online SLICE: a tool for continuous monitoring of respiratory mechanics
por: Möller, K, et al.
Publicado: (2006)

Combining National Early Warning Score With Soluble Urokinase Plasminogen Activator Receptor (suPAR) Improves Risk Prediction in Acute Medical Patients: A Registry-Based Cohort Study*
por: Rasmussen, Line J. H., et al.
Publicado: (2018)

Evaluating the sensitivity and specificity of a severe sepsis tool utilized at a community hospital in Miami, FL
por: Hirigoyen, J
Publicado: (2014)

High suPAR and Low Blood Eosinophil Count are Risk Factors for Hospital Readmission and Mortality in Patients with COPD
por: Håkansson, Kjell E J, et al.
Publicado: (2020)

Comparison between intravital microscopy and laser Doppler microcirculation monitoring methods in experimental sepsis: preliminary results
por: Büchele, GL, et al.
Publicado: (2005)

suPAR: The Molecular Crystal Ball
por: Thunø, Maria, et al.
Publicado: (2009)

Activated protein C–protein C inhibitor complex as a prognostic marker in sepsis
por: Heslet, Lars, et al.
Publicado: (2008)

Elevated suPAR Is an Independent Risk Marker for Incident Kidney Disease in Acute Medical Patients
por: Iversen, Esben, et al.
Publicado: (2020)

Daily blood sampling in septic mice: an optimal and effective monitoring tool
por: Weixelbaumer, Katrin Maria, et al.
Publicado: (2008)

LightCycler SeptiFast assay as a tool for the rapid diagnosis of sepsis in patients receiving antimicrobial therapy
por: Vince, Adriana, et al.
Publicado: (2008)

An epidemiological study of sepsis in ICUs: Sepsis Brazil Study
por: Sales, J, et al.
Publicado: (2006)

P372: Reduction of HAI Legionella pneumophilia pneumonia and Pseudomonas aeruginosa sepsis by control with water supply
por: Andersen, LP, et al.
Publicado: (2013)

Systemic inflammatory response syndrome as a clinical detection tool and inclusion criterion in sepsis trials: too blunt an instrument?
por: Gille-Johnson, P, et al.
Publicado: (2008)

Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation
por: Rasmussen, Line Jee Hartmann, et al.
Publicado: (2021)

21. Sepsis?
por: Zacharias, Hannah, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b64phvufcbnnujo64i342bfiid